InvestorsObserver
×
News Home

What is Wall Street's Target Price for Achieve Life Sciences Inc (ACHV) Stock?

Friday, January 15, 2021 03:09 PM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for Achieve Life Sciences Inc (ACHV) Stock?

InvestorsObserver is giving Achieve Life Sciences Inc (ACHV) an Analyst Rating Rank of 79, meaning ACHV is ranked higher by analysts than 79% of stocks. The average projection by analysts for ACHV is $45 over the next 12 months and analyst’s classify the stock as a Strong Buy

Overall Score - 5
Wall Street analysts are rating ACHV a Strong Buy today. Find out what this means to you and get the rest of the rankings on ACHV!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.

InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Achieve Life Sciences Inc Stock Today?

Achieve Life Sciences Inc (ACHV) stock has risen 7.26% while the S&P 500 is down -0.45% as of 3:06 PM on Friday, Jan 15. ACHV is up $0.66 from the previous closing price of $9.09 on volume of 296,404 shares. Over the past year the S&P 500 has risen 13.92% while ACHV is down -18.68%. ACHV lost -$8.76 per share the over the last 12 months.

Click Here to get the full report on Achieve Life Sciences Inc (ACHV) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App